EnglishGermanHebrewKorean
  • CEO

Ethics

Management that places corporate ethical compliance with an assertive attitude as the code of conduct

CP Activities

MAXIPLUS MEDICAL & PHARMACEUTICAL is actively engaged in the CP activities.

2018
ISO37001 certification
※ International standard anti-corruption management system
2017
Received AA rating in CP rating 2 consecutive times
(first in the pharmaceutical industry)
Send CP letters to all management and employees twice a month
(send relevant laws/regulations and issues)
Constructed ‘economic profit expenditure report’ system
2016
Pre-post inspection for constructing a CP monitoring CES system
Publish CP FAQ guidebook
Newly establish the MAXIPLUS MEDICAL & PHARMACEUTICAL ‘webzine’ compliance board
CP work organization → Legal team/CP team operated separately
2015
Received AA rating in CP ratings
(first in the pharmaceutical industry, highest rating)
Awarded ‘Presidential Medal’ on Fair Trade Day for autonomous compliance manager
Published 4th CP handbook
Foster holders of grade 1 compliance management experts
Operate legal CP team (appointed legal advisor attorney)
2014
Published third CP handbook
Newly organized CP team directly under the CEO
In-company cyber classroom
Newly established fair trade training course
(8 classes, supported by the company)
Published ethical management handbook
2011
Published second CP handbook
Enacted integrated CP regulations for Maxiplus Group
2008 Compliance Program history
Published the first CP handbook in the pharmaceutical industry
2007
Introduced fair trade autonomous compliance program
Established compliance organization